Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on April 25, 2025
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Spryker von RetailTech Breakthrough als „E-Commerce-Lösung des Jahres 2025“ ausgezeichnet
GlobeNewswire
·
April 25, 2025
BERLIN und NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Spyker, die führende Composable-Commerce-Plattform für anspruchsvolle Anwendungsfälle im B2B-Commerce, Enterprise Marketplaces und IoT Commerce, hat heute bekanntgegeben, dass das Unternehmen im …
Spryker est nommée « Solution e-commerce de l’année » 2025 par RetailTech Breakthrough
GlobeNewswire
·
April 25, 2025
BERLIN et NEW YORK, 25 avr. 2025 (GLOBE NEWSWIRE) -- Spryker, la principale plateforme de commerce modulaire pour les cas d’utilisation sophistiqués autour du B2B Commerce, des Enterprise Marketplaces et de l’IoT Commerce, a annoncé aujourd’hui avoir reçu …
Bitcoin has skyrocketed recently – SIX MINING provides you with stable passive income
GlobeNewswire
·
April 25, 2025
London, UK, April 25, 2025 (GLOBE NEWSWIRE) -- London, UK Apr 24, 2025 (Copper) Affected by the latest trade policy of US President Donald Trump, the global market is volatile, but cryptocurrencies are rising against the trend - Bitcoin has broken through …
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
GlobeNewswire
·
April 25, 2025
SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!
GlobeNewswire
·
April 25, 2025
MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- Flush Factor Plus is a natural dietary supplement that claims to support fluid retention and promote joint mobility and flexibility. Knee pain and joint issues due to improper fluid circulation are common issues …
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
GlobeNewswire
·
April 25, 2025
Raanana, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful …
ALDX SHAREHOLDERS: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) 75% Stock Drop Triggers Investigation – Contact BFA Law if You Lost Money
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
FLNC SHAREHOLDERS: Fluence Energy, Inc. (NASDAQ:FLNC) 46% Stock Drop Triggers Class Action – Contact BFA Law by May 12 if You Lost Money
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
TBBK SHAREHOLDERS: The Bancorp, Inc. (NASDAQ:TBBK) 28% Stock Drop Triggers Class Action – Contact BFA Law by May 16 if You Lost Money
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
VTRS SHAREHOLDERS: Viatris Inc. (NASDAQ:VTRS) 15% Stock Drop Triggers Class Action – Contact BFA Law by June 3 if You Lost Money
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …
Saia Reports First Quarter Results
GlobeNewswire
·
April 25, 2025
JOHNS CREEK, Ga., April 25, 2025 (GLOBE NEWSWIRE) -- Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, today reported first quarter 2025 …
PONY AI Inc. and Tencent Cloud Announce Strategic Partnership to Advance Autonomous Driving Technology and Robotaxi Commercial Deployment
GlobeNewswire
·
April 25, 2025
SHANGHAI, China, April 25, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, announced a strategic partnership with Tencent Cloud and Smart …
Echo Launches Real Unique Tokenomics with Real Yield in USDC
GlobeNewswire
·
April 25, 2025
Douglas, Isle of Man, April 25, 2025 (GLOBE NEWSWIRE) -- Echo is about to launch a digital asset that intersects trading income with blockchain openness. The echo token, set to go live on May 15th, has a long list of promises for Web3 fans. The token’s …
Lakeland Financial Reports a 12% Increase in Net Interest Income and Organic Loan Growth of 4%
GlobeNewswire
·
April 25, 2025
WARSAW, Ind., April 25, 2025 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $20.1 million for the three months ended March 31, 2025, which represents a decrease …
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
GlobeNewswire
·
April 25, 2025
BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call
GlobeNewswire
·
April 25, 2025
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced …
BingEx Limited Files Its 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 25, 2025
BEIJING, April 25, 2025 (GLOBE NEWSWIRE) -- BingEx Limited (the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier service provider in China (branded as “FlashEx”), today announced that it filed its annual report on Form 20-F for the fiscal …
Atour Lifestyle Holdings Limited Releases 2024 Environmental, Social and Governance Report
GlobeNewswire
·
April 25, 2025
SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced the release of its 2024 Environmental, Social and Governance (“ …